doi: 10.1016/s0140-6736(78)90724-9.
Genetically determined defcts of oxidation at carbon centres of drugs
- PMID: 76883
- DOI: 10.1016/s0140-6736(78)90724-9
Item in Clipboard
Genetically determined defcts of oxidation at carbon centres of drugs
Lancet.
.
No abstract available
Similar articles
-
Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.Drug Metab Rev. 1979;9(2):301-17. doi: 10.3109/03602537908993896. Drug Metab Rev. 1979. PMID: 158499 Review. No abstract available.
-
Polymorphism of carbon oxidation of drugs and clinical implications.Br Med J. 1978 Sep 2;2(6138):655-7. doi: 10.1136/bmj.2.6138.655. Br Med J. 1978. PMID: 151576 Free PMC article.
-
Genetic evidence for the involvement of different oxidative mechanisms in drug oxidation.J Pharm Pharmacol. 1979 May;31(5):350-2. doi: 10.1111/j.2042-7158.1979.tb13520.x. J Pharm Pharmacol. 1979. PMID: 37314 No abstract available.
-
[Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].Internist (Berl). 1983 Mar;24(3):117-27. Internist (Berl). 1983. PMID: 6135670 Review. German. No abstract available.
-
[Heritable polymorphisms in oxidative drug metabolism].Duodecim. 1990;106(5):408-14. Duodecim. 1990. PMID: 1670108 Review. Finnish. No abstract available.
Cited by
-
Functional Significance of Cytochrome P450 1A2 Allelic Variants, P450 1A2*8, *15, and *16 (R456H, P42R, and R377Q).Biomol Ther (Seoul). 2015 Mar;23(2):189-94. doi: 10.4062/biomolther.2015.009. Epub 2015 Mar 1. Biomol Ther (Seoul). 2015. PMID: 25767688 Free PMC article.
-
Genetically determined variability in acetylation and oxidation. Therapeutic implications.Drugs. 1985 Apr;29(4):342-75. doi: 10.2165/00003495-198529040-00003. Drugs. 1985. PMID: 2859977 Review.